Rezolute (RZLT) Non-Current Assets (2012 - 2026)
Rezolute's (RZLT) quarterly Non-Current Assets came in at $3.4 million in Q1 2026, down 43.2% year-on-year from $6.0 million in Q1 2025, and down 3.21% quarter-over-quarter from $3.5 million in Q4 2025.
Rezolute (RZLT) Non-Current Assets (2012 - 2026) Analysis & Trends
Rezolute has disclosed Non-Current Assets across 15 years of filings, most recently posting $3.4 million for Q1 2026.
- Non-Current Assets for Q1 2026 came in at $3.4 million, down 43.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.2 million (down 58.42% YoY), and the FY2025 annual result was $4.3 million, up 6.39% from the prior year.
- Non-Current Assets came in at $3.4 million for Q1 2026 at Rezolute, down from $3.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $28.7 million in Q1 2023 to a low of $316000.0 in Q2 2022.
- The 5-year median for Non-Current Assets is $5.2 million (2022), against an average of $7.6 million.
- Across the five-year window, Non-Current Assets jumped 5852.85% in 2023 and sank 80.73% in 2024, its largest moves.
- Rezolute's Non-Current Assets stood at $2.6 million in 2022, then surged by 133.09% to $6.1 million in 2023, then soared by 119.51% to $13.3 million in 2024, then plunged by 73.54% to $3.5 million in 2025, then retreated by 3.21% to $3.4 million in 2026.
- The last three Non-Current Assets figures came in at $3.4 million (Q1 2026), $3.5 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 3.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 3.52 Mn |
| Sep 30, 2025 | 3.96 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 13.24 Mn |
| Jun 30, 2024 | 4.08 Mn |
| Mar 31, 2024 | 5.53 Mn |
| Dec 31, 2023 | 6.07 Mn |
| Sep 30, 2023 | 10.35 Mn |
| Jun 30, 2023 | 18.81 Mn |
| Mar 31, 2023 | 28.68 Mn |
| Dec 31, 2022 | 2.60 Mn |
| Sep 30, 2022 | 361,000.00 |
| Jun 30, 2022 | 316,000.00 |
| Mar 31, 2022 | 5.24 Mn |
| Dec 31, 2021 | 5.31 Mn |
| Sep 30, 2021 | 415,000.00 |
| Jun 30, 2021 | 616,000.00 |